Details for Patent: 11,649,217
Which drugs does patent 11,649,217 protect, and when does it expire?
Patent 11,649,217 protects JESDUVROQ and is included in one NDA.
This patent has eight patent family members in seven countries.
Summary for Patent: 11,649,217
| Title: | Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof |
| Abstract: | The present disclosure relates to crystalline form CS1 and CS9 of a hypoxia-inducible factor prolyl hydroxylase inhibitor compound (I) GSK1278863, processes for preparation, and uses for preparing drugs treating and/or preventing anemia thereof. |
| Inventor(s): | Minhua Chen, Yanfeng Zhang, Jinqiu WANG, Xiaoyu Zhang |
| Assignee: | GlaxoSmithKline Intellectual Property No 2 Ltd |
| Application Number: | US17/174,006 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,649,217
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-001 | Feb 1, 2023 | DISCN | Yes | No | 11,649,217 | ⤷ Start Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Start Trial | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-002 | Feb 1, 2023 | DISCN | Yes | No | 11,649,217 | ⤷ Start Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Start Trial | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-003 | Feb 1, 2023 | DISCN | Yes | No | 11,649,217 | ⤷ Start Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Start Trial | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-004 | Feb 1, 2023 | DISCN | Yes | No | 11,649,217 | ⤷ Start Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Start Trial | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-005 | Feb 1, 2023 | DISCN | Yes | No | 11,649,217 | ⤷ Start Trial | Y | A METHOD OF TREATING ANEMIA | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,649,217
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018330994 | ⤷ Start Trial | |||
| Canada | 3112277 | ⤷ Start Trial | |||
| China | 111093668 | ⤷ Start Trial | |||
| European Patent Office | 3682884 | ⤷ Start Trial | |||
| Spain | 2980121 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
